1a|Title (Randomized)
1b|Structured Abstract
2a|Background
2b|Objective
3a|Trial Design
3b|Changes TO Trial Design
4a|Eligibility Criteria
4b|Data Collection Setting
5|Interventions
6a|Outcomes
6b|Changes to Outcomes
7a|Sample Size Determination
7b|Interim Analyses/Stopping Guidelines
8a|Random Allocation Sequence Generation
8b|Randomization Type
9|Allocation Concealment Mechanism
10|Randomization Implementation
11a|Blinding Procedure
11b|Similarity of Interventions
12a|Statistical Methods for Outcome Comparison
12b|Statistical Methods for Other Analyses
13a|Participant Flow
13b|Participant Loss and Exclusion
14a|Recruitment Period/Follow-Up
14b|Trial Stopping
15|Baseline Data
16|Numbers Analyzed
17a|Outcome Results
17b|Binary Outcome Results
18|Ancillary Analyses
19|Harms
20|Limitations
21|Generalizability
22|Interpretation
23|Registry/Number
24|Protocol Access
25|Funding